Samsung Biologics Co.,Ltd.

KOSE:A207940 Stock Report

Market Cap: ₩66.3t

Samsung BiologicsLtd Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

John Chongbo Rim

Chief executive officer

₩6.6b

Total compensation

CEO salary percentage18.2%
CEO tenure3.9yrs
CEO ownershipn/a
Management average tenure1.8yrs
Board average tenure4.7yrs

Recent management updates

Recent updates

Samsung Biologics Co.,Ltd. (KRX:207940) Investors Are Less Pessimistic Than Expected

Nov 11
Samsung Biologics Co.,Ltd. (KRX:207940) Investors Are Less Pessimistic Than Expected

These 4 Measures Indicate That Samsung BiologicsLtd (KRX:207940) Is Using Debt Reasonably Well

Sep 09
These 4 Measures Indicate That Samsung BiologicsLtd (KRX:207940) Is Using Debt Reasonably Well

Samsung Biologics Co.,Ltd.'s (KRX:207940) 26% Share Price Surge Not Quite Adding Up

Jul 29
Samsung Biologics Co.,Ltd.'s (KRX:207940) 26% Share Price Surge Not Quite Adding Up

Does Samsung BiologicsLtd (KRX:207940) Have A Healthy Balance Sheet?

May 27
Does Samsung BiologicsLtd (KRX:207940) Have A Healthy Balance Sheet?

What Samsung Biologics Co.,Ltd.'s (KRX:207940) P/E Is Not Telling You

Apr 14
What Samsung Biologics Co.,Ltd.'s (KRX:207940) P/E Is Not Telling You

With EPS Growth And More, Samsung BiologicsLtd (KRX:207940) Is Interesting

Mar 01
With EPS Growth And More, Samsung BiologicsLtd (KRX:207940) Is Interesting

These 4 Measures Indicate That Samsung BiologicsLtd (KRX:207940) Is Using Debt Reasonably Well

Jan 18
These 4 Measures Indicate That Samsung BiologicsLtd (KRX:207940) Is Using Debt Reasonably Well

What Kind Of Shareholders Own Samsung Biologics Co.,Ltd. (KRX:207940)?

Dec 28
What Kind Of Shareholders Own Samsung Biologics Co.,Ltd. (KRX:207940)?

How Much Is Samsung Biologics Co.,Ltd. (KRX:207940) CEO Getting Paid?

Dec 08
How Much Is Samsung Biologics Co.,Ltd. (KRX:207940) CEO Getting Paid?

Did You Miss Samsung BiologicsLtd's (KRX:207940) Impressive 112% Share Price Gain?

Nov 18
Did You Miss Samsung BiologicsLtd's (KRX:207940) Impressive 112% Share Price Gain?

CEO Compensation Analysis

How has John Chongbo Rim's remuneration changed compared to Samsung BiologicsLtd's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2024n/an/a

₩1t

Mar 31 2024n/an/a

₩895b

Dec 31 2023₩7b₩1b

₩858b

Sep 30 2023n/an/a

₩937b

Jun 30 2023n/an/a

₩826b

Mar 31 2023n/an/a

₩793b

Dec 31 2022₩5b₩1b

₩798b

Sep 30 2022n/an/a

₩507b

Jun 30 2022n/an/a

₩510b

Mar 31 2022n/an/a

₩480b

Dec 31 2021₩3b₩598m

₩394b

Sep 30 2021n/an/a

₩410b

Jun 30 2021n/an/a

₩335b

Mar 31 2021n/an/a

₩265b

Dec 31 2020₩995m₩421m

₩241b

Sep 30 2020n/an/a

₩355b

Jun 30 2020n/an/a

₩343b

Mar 31 2020n/an/a

₩278b

Dec 31 2019₩1b₩497m

₩203b

Compensation vs Market: John Chongbo's total compensation ($USD4.73M) is above average for companies of similar size in the KR market ($USD1.48M).

Compensation vs Earnings: John Chongbo's compensation has increased by more than 20% in the past year.

CEO

John Chongbo Rim (63 yo)

3.9yrs

Tenure

₩6,600,000,000

Compensation

Mr. John Chongbo Rim serves as Chairman of Samsung Biologics Co.,Ltd. since March 17, 2023. He has been the CEO & President of Samsung Biologics Co.,Ltd.since December 16, 2020. Mr. Rim has been Director...

Leadership Team

NamePositionTenureCompensationOwnership
John Chongbo Rim
CEO, President & Chairman of Board3.9yrs₩6.60bno data
Dong-Joong Kim
CFO, Executive VP9.9yrs₩1.20b0.0065%
₩ 4.3b
Kun Lo
Executive VPno data₩879.50mno data
Pierre Catignol
Executive VP & Head of Operation Centerless than a yearno datano data
Namjin Chung
Executive VP and Head of Bio R&D Centre & CSO1.9yrsno datano data
James J. Choi
Executive VP1.8yrs₩569.00mno data
Kyuho Lee
Executive VPless than a yearno datano data
Brian Hosung Min
Executive VP & Head of CDO Development Center1.8yrsno datano data
Doyoung Heo
Vice President & Head of Financeno datano datano data
Heekyun Lim
VP & Head of Business Consulting Teamno datano datano data
Yong Park
VP & Head of HR Planning Departmentless than a yearno datano data
Sangwon Seo
VP and Head of Sales & Operation Departmentno datano datano data

1.8yrs

Average Tenure

56.5yo

Average Age

Experienced Management: A207940's management team is not considered experienced ( 1.8 years average tenure), which suggests a new team.

Board Members

NamePositionTenureCompensationOwnership
John Chongbo Rim
CEO, President & Chairman of Board4.7yrs₩6.60bno data
Dong-Joong Kim
CFO, Executive VP5.7yrs₩1.20b0.0065%
₩ 4.3b
Kun Lo
Executive VP1.7yrs₩879.50mno data
Kyonghee Kim
Independent Outside Director4.7yrsno datano data
Changwoo Lee
Independent Directorno datano datano data
Geunnyeong Heo
Independent Director5.7yrsno datano data
Seoung Hwan Suh
Independent Directorless than a yearno datano data

4.7yrs

Average Tenure

62yo

Average Age

Experienced Board: A207940's board of directors are considered experienced (4.7 years average tenure).